TGFBI and prostate carcinoma: To determine whether DKK3, TGFBI, and ECM1 mRNA expression is associated with prostate cancer patient survival, we used PROGgene (http://www.compbio.iupui.edu/proggene) [31, 32] and the Prostate cancer dataset GSE70768 [33].